Sign In
Buy HSIC
$75.74
-0.300 (-0.395%)
At Close: Jun 03, 2026
Henry Schein to Participate in Upcoming Investor Conferences in March
06:30am, Tuesday, 03'rd Mar 2026
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will prese
Why Henry Schein (HSIC) is a Top Growth Stock for the Long-Term
10:46am, Monday, 02'nd Mar 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Henry Schein (NASDAQ:HSIC) CEO Sells $875,742.00 in Stock
05:34am, Monday, 02'nd Mar 2026
Henry Schein, Inc. (NASDAQ: HSIC - Get Free Report) CEO Stanley Bergman sold 10,785 shares of the firm's stock in a transaction dated Friday, February 27th. The shares were sold at an average price of
Reviewing West Pharmaceutical Services (NYSE:WST) and Henry Schein (NASDAQ:HSIC)
01:28am, Monday, 02'nd Mar 2026
West Pharmaceutical Services (NYSE: WST - Get Free Report) and Henry Schein (NASDAQ: HSIC - Get Free Report) are both medical companies, but which is the better business? We will contrast the two comp
Henry Schein, Inc. $HSIC Shares Purchased by Artisan Partners Limited Partnership
03:26am, Friday, 27'th Feb 2026
Artisan Partners Limited Partnership raised its position in Henry Schein, Inc. (NASDAQ: HSIC) by 5.7% during the undefined quarter, according to its most recent filing with the Securities and Exchange
Henry Schein, Inc. (HSIC) Q4 2025 Earnings Call Transcript
03:27pm, Tuesday, 24'th Feb 2026
Henry Schein, Inc. (HSIC) Q4 2025 Earnings Call Transcript
Henry Schein Inc (HSIC) Q4 2025 Earnings Call Highlights: Record Sales Growth and Strategic Advancements
02:03pm, Tuesday, 24'th Feb 2026
Global Sales: $3.4 billion, growth of 7.7% compared to Q4 2024.GAAP Operating Margin: 4.76%, a decrease of 10 basis points year-over-year.Non-GAAP Operating Ma
Henry Schein Stock Hits 52-Week High - Here's Why
01:55pm, Tuesday, 24'th Feb 2026
Global Distribution and Value-Added Services sales rose 7.0% to $2.89 billion in the fourth quarter, up 5.2% on a constant-currency basis from the year-ago period.
Henry Schein (HSIC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
10:30am, Tuesday, 24'th Feb 2026
The headline numbers for Henry Schein (HSIC) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street
HSIC Q4 Earnings & Revenues Beat Estimates, Margins Down
09:51am, Tuesday, 24'th Feb 2026
Henry Schein tops Q4 estimates with 7.8% sales growth, but margin contraction tempers strong equipment, specialty and tech gains.
Henry Schein beats quarterly profit estimates on strong dental, medical equipment sales
08:40am, Tuesday, 24'th Feb 2026
Henry Schein on Tuesday beat fourth-quarter profit estimates and forecast annual profit largely in line with Wall Street expectations on the back of stabilizing demand for its dental and medical equip
Henry Schein (HSIC) Surpasses Q4 Earnings and Revenue Estimates
08:35am, Tuesday, 24'th Feb 2026
Henry Schein (HSIC) came out with quarterly earnings of $1.34 per share, beating the Zacks Consensus Estimate of $1.3 per share. This compares to earnings of $1.19 per share a year ago.
Henry Schein Reports Fourth Quarter and Full Year 2025 Financial Results and Introduces 2026 Financial Guidance
06:00am, Tuesday, 24'th Feb 2026
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial res
Henry Schein One Launches Image Verify, Another Transformative Step Towards Achieving the Cleanest Claims in the Industry
06:30am, Thursday, 19'th Feb 2026
AMERICAN FORK, Utah--(BUSINESS WIRE)--Henry Schein One, the market leader in dental practice management systems, today announced the launch of AI-driven Image Verify, the latest innovation in a rapid
Henry Schein, Inc. $HSIC Shares Sold by Rhumbline Advisers
04:18am, Wednesday, 18'th Feb 2026
Rhumbline Advisers trimmed its holdings in shares of Henry Schein, Inc. (NASDAQ: HSIC) by 3.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange
